Multiple paradoxical adverse events in a patient with ankylosing spondylitis treated with adalimumab

被引:0
|
作者
Éric Toussirot
Romain Charollais
François Aubin
机构
[1] University Hospital of Besançon,Clinical Investigation Centre in Biotherapy, INSERM CIC
[2] University Hospital of Besançon,1431
[3] University Hospital of Besançon,FHU INCREASE
[4] University of Franche-Comté,Department of Rheumatology
[5] University Hospital of Besançon,Department of Therapeutics and UPRES EA 4266: “Pathogenic agents and Inflammation”
[6] University of Franche-Comté,Department of Dermatology
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:406 / 408
页数:2
相关论文
共 50 条
  • [41] Predictors of Response, Adverse Events and Treatment Retention in Ankylosing Spondylitis Patients Treated with Golimumab in a Prospective, Observational Registry
    Rahman, Proton
    Masetto, Ariel
    Teo, Michelle
    Boulos, Pauline
    Sholter, Dalton
    Kapur, Suneil
    Rampakakis, Emmanouil
    Rachich, Meagan
    Asin-Milan, Odalis
    Lehman, Allen
    Nantel, Francois
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [42] Predictors of Response, Adverse Events and Treatment Retention in Ankylosing Spondylitis Patients Treated with Golimumab in a Prospective, Observational Registry
    Rahman, Proton
    Masetto, Ariel
    Teo, Michelle
    Boulos, Pauline
    Sholter, Dalton
    Kapur, Suneil
    Rampakakis, Emmanouil
    Rachich, Meagan
    Asin-Milan, Odalis
    Lehman, Allen
    Nantel, Francois
    JOURNAL OF RHEUMATOLOGY, 2020, 47 (07) : 1048 - 1048
  • [43] CASE OF A FEMALE PATIENT WITH ANKYLOSING SPONDYLITIS AND MULTIPLE ANEURYSMS
    Stoimenov, Blagovest
    Gaydarski, Lyubomir
    Dineva, Svetla
    Pancheva, Ralitsa
    JOURNAL OF IMAB, 2024, 30 (01): : 5308 - 5313
  • [44] In Patients with Ankylosing Spondylitis Treated with Adalimumab, Combination Therapy with DMARD, Increase the Serum Level of Adalimumab and Decrease Immunogenicity
    Rosas, Jose
    Llinares-Tello, Francisca
    Miguel Senabre-Gallego, Jose
    Marco-Mingot, Mariana
    Pons, Ana
    Barber, Xavier
    Santos-Soler, Gregorio
    Salas-Heredia, Esteban
    Cano, Catalina
    Molina, Juan
    Sanchis, Marina
    Garcia-Carrasco, Mario
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [45] Paradoxical Psoriasis and Worsening Spondylitis Due to Secukinumab in a Patient With Ankylosing Spondylitis: A Case Report and Literature Review
    Alnaqbi, Khalid A.
    Al Zeyoudi, Jawaher
    Fazal, Fahad
    Alhaj, Omar M.
    Jassim, Imad
    Albreiki, Fatima A.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (12)
  • [46] Comparison of drug survival and clinical outcome in patients with ankylosing spondylitis treated with etanercept or adalimumab
    Ruwaard, J.
    l'Ami, M. J.
    Marsman, A. F.
    Kneepkens, E. L.
    van Denderen, J. C.
    van der Horst-Bruinsma, I. E.
    Nurmohamed, M. T.
    Wolbink, G.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2018, 47 (02) : 122 - 126
  • [47] DECREASED RECURRENCE RATE OF ANTERIOR UVEITIS IN ANKYLOSING SPONDYLITIS TREATED WITH ADALIMUMAB - AN INTERIM ANALYSIS
    van der Horst-Bruinsma, I. E.
    van Denderen, J. C.
    Visman, I
    Suttorp-Schulten, M. S. A.
    Dijkmans, B. A. C.
    Nurmohamed, M. T.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (04) : 630 - 630
  • [48] Preliminary MRI results in patients with active ankylosing spondylitis treated with adalimumab for 12 weeks
    Haibel, H
    Rudwaleit, M
    Brandt, HC
    Grozdanovic, Z
    Braun, J
    Kupper, H
    Sieper, J
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S618 - S618
  • [49] A Case of Adalimumab-Induced Psoriasiform Dermatitis in an Ankylosing Spondylitis Patient: Unusual Progression after Adalimumab Retreatment
    Yoon, Ji Ha
    Jung, Joon Woo
    Park, Eun Joo
    Kim, Kwang Joong
    Kim, Kwang Ho
    ANNALS OF DERMATOLOGY, 2022, 34 (05) : 396 - 398
  • [50] Real-life Tolerability and Effectiveness of Adalimumab Biosimilar in Ankylosing Spondylitis: the Adalimumab Biosimilar Patient Registry Data
    Kapoor, Sanjiv
    Kaushik, Viswanath V.
    Jain, Rahul
    Rao, Vijay K. R.
    Gharia, Mihir
    ACR OPEN RHEUMATOLOGY, 2019, 1 (08) : 480 - 484